Visceral adipose tissue resection

Visceral adipose tissue resection has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Feb 6, 2026: “Small extracellular vesicle-mediated adipocyte-cardiomyocyte crosstalk exacerbates heart failure with preserved ejection fraction”.

Exposure

1 paper studies it1 findingUpdated

See all 1 papers on visceral adipose tissue resection

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Beijing Municipal Natural Science Foundation and 4 more
  • Animals1

What did studies of visceral adipose tissue resection find?

1

Studies of visceral adipose tissue resection measured one outcome, heart failure with preserved ejection fraction.

Heart failure with preserved ejection fraction

downin mice1

1 study
  1. Visceral adipose tissue resection decreases heart failure with preserved ejection fraction in HFpEF mice.

    “Resection or transplantation of visceral adipose tissue (VAT) blunted or exacerbated HFpEF phenotypes, respectively, in mice.”

    Animalsin HFpEF miceheartmales

    Small extracellular vesicle-mediated adipocyte-cardiomyocyte crosstalk exacerbates heart failure with preserved ejection fraction

    Cardiovascular research

More on Heart failure with preserved ejection fraction

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months